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Abstract 
Background: Adapalene is a retinoid analogue with actions similar to those of tretinoin. It is used in topical treat‑
ment of mild to moderate acne. A survey of the literature reveals that no spectrofluorimetric method has been 
reported yet for determination of ADP, so it was thought necessary to develop a highly sensitive stability indicating 
spectrofluorimetric method.
Results: Two highly sensitive spectrofluorimetric approaches were conducted for the assay of adapalene (ADP) in 
its gel. In the first approach, ADP exhibits an intense native fluorescence at 389 nm after excitation at 312 nm using 
borate buffer (pH 7.0)/ethanol system. This approach was successfully applied for routine analysis of ADP in its gel 
and ideally suited to the in vitro diffusion test. To elucidate the inherent stability of ADP, bulk sample was subjected to 
different stress conditions as specified by ICH guidelines. The acidic and oxidative degradation products were resolved 
from the intact drug using second and first derivative synchronous fluorimetry at 346 and 312.45 nm, respectively 
(the second approach). The synchronous fluorescence was scanned at Δ λ of 80 nm in case of acidic degradation and 
at Δ λ of 100 nm in case of oxidative degradation. Good linearity was obtained for ADP over the range 2.0–14.0 ng/mL 
with good correlation coefficient   0.999 in each approach. The approaches were carefully examined in terms of linear‑
ity, accuracy and precision. They were suitable for routine quality control laboratory. Moreover, the stability‑indicating 
power of the second approach was ascertained via forced degradation studies.
Conclusions: The proposed approaches were validated and successfully applied for the quantitative assay of a small 
concentration of ADP in its pharmaceutical gel. The conventional spectrofluorimetry was ideally suited for in vitro 
diffusion test. Stability studies were also conducted using different forced degradation condition according to ICH 
recommendation.
© 2016 The Author(s). This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Background
Chemically, adapalene (ADP) is 6-[3-(1-Adamantyl)-
4-methoxyphenyl]-2-naphthoic acid (Fig.  1). It is a 
naphthoic acid derivative and retinoid analogue with 
actions similar to those of tretinoin. It is used in 
topical treatment of mild to moderate acne [1]. ADP 
is a subject of monograph in European Pharmacopoeia 
[2].
Only few analytical methods were reported for the 
assay of ADP. These methods include high performance 
liquid chromatography (HPLC) [3–8]. In addition, only 
two derivative spectrophotometric methods were applied 
for ADP determination in bulk drug and pharmaceutical 
dosage form [9] or in liposomes [10].
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International Conference on Harmonization (ICH) 
guideline Q1A on stability testing of new drug substances 
and products requires that stress testing be carried out 
to elucidate the inherent stability features of the active 
substance which may be changed during storage and so, 
ensure high quality, safety, and efficacy of the pharma-
ceutical product [11].
Moreover, the development of in  vitro release study 
serves as a good quality control tool to ensure batch to 
batch uniformity and screen experimental formulation 
during the product development. Determination of the 
value of in vitro release helps to cross check the product 
quality and product comparison [12].
A comprehensive literature survey revealed that no 
spectrofluorimetric method has been reported yet for 
the determination of ADP in its gel or in presence of its 
degradation products. The reported methods concerned 
with the stability of ADP are expensive, time consum-
ing, sophisticated HPLC techniques [3–6]. Most of these 
methods suffer from low sensitivity which restricted the 
determination of ADP in low concentration in presence 
of its degradation products. Moreover, some of these 
methods showed narrow linearity range [5, 6] or failed to 
separate the acidic and oxidative degradation products 
from the parent drug [3, 6]. Regarding the pharmaceuti-
cal application, none of these methods are applicable to 
in  vitro dissolution test which is an important issue in 
quality control laboratories.
Therefore, it was thought necessary to develop sensitive 
stability indicating spectrofluorimetric method for deter-
mination of ADP and applicable to in vitro diffusion test.
In our study, two extremely sensitive spectrofluorimet-
ric approaches were explored for the analysis of a very 
small concentration of ADP down to 2.0  ng/mL. ADP 
shows a strong native fluorescence at 389/312 nm (λem/
λex) in borate buffer (pH 7.0)/ethanol system. Depend-
ing on this fact, the first approach was conducted and 
extended to study the inherent stability of ADP and the 
in  vitro diffusion test. Great overlapping between the 
fluorescence spectra of ADP and its degradation prod-
ucts were observed, therefore, we resorted to deriva-
tive synchronous fluorimetry (DSF). Where, ADP was 
resolved from its acidic and oxidative degradation prod-
ucts by second (SDSF) and first (FDSF) derivative syn-
chronous fluorimetry at 346 and 312.45 nm, respectively.
Experimental
Apparatus
  – All fluorescence measurements were recorded with 
a  Perkin-Elmer UK model LS 45 luminescence spec-
trometer, equipped with a 150  W Xenon arc lamp, 
grating excitation and emission monochromators and 
a Perkin Elmer recorder. The slit widths were 10 nm for 
both excitation and emission, and the photomultiplier 
voltage was set to automatic option. Derivative spectra 
were obtained using fluorescence data manager soft-
ware, FL WINLAB, Version 4.00.02, Copyright 2001, 
Perkin Elmer, Inc., UK.
  – A Consort P-901 pH-meter was used for pH measure-
ments.
  – Thermostatically controlled shaking water bath (Grant 
instrument Cambridge Ltd., Barrington Cambridge B2, 
5002, England).
  – Modified Franz diffusion cell.
  – CAMAG UV-lamp, S/N 29000, dual wavelength 
254/366 nm, 2 × 8 Watt (Switzerland) was used in the 
UV-degradation study.
Materials and reagents
All the chemicals used were of analytical reagent grade, 
and the solvents were of HPLC grade.
  • Adapalene was supplied by Glenmark (Cairo, Egypt) 
with a certified purity of 99.70  % and was used as 
received without further purification.
  • Adapalene® gel; batch # 011371, labeled to contain 
0.1  % ADP (product of Borg Pharmaceutical Ind., 
Alexandria, Egypt). It was purchased from the local 
pharmacy.
  • Ethanol (Fisher Scientific UK, Loughborough, Leics, 
UK).
  • Acetonitrile, n-propanol and methanol were obtained 
from Tedia (USA).
  • Boric acid, sodium acetate trihydrate, acetic acid 
96  %, acetone, dimethyl formamide (DMF), methyl 
cellulose (MC), tween-80, sodium hydroxide, hydro-
gen peroxide (30  %) and hydrochloric acid (32  %) 
were all obtained from El-Nasr Pharmaceutical 
Chemicals Company (ADWIC) (Abu Zaabal, Egypt).
  • Sodium dodecyl sulphate (SDS; 95 %), β-cyclodextrin 
(β-CD), cetrimide (CTAB; 99  %) were purchased 
from Winlab (UK).
Fig. 1 The structural formula for adapalene (ADP)
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Standard solutions
Stock solution equivalent to 100.0  µg/mL of ADP was 
prepared by dissolving 10.0  mg in 100.0  mL ethanol. 
Other standard solution equivalent to 100.0  ng/mL was 
prepared by appropriate dilution of the stock solution 
with the same solvent. The solutions were found to be 




Aliquots of ADP standard solution were transferred into 
a series of 10 mL volumetric flasks so that the final con-
centration was in the range of 2.0–14.0 ng/mL. Then, 2 mL 
borate buffer (0.2 M, pH 7.0) was added to each flask fol-
lowed by completing the volume with ethanol and mixing 
well. For the first approach, the fluorescence intensities of 
the solutions were measured at 389  nm after excitation 
at 312  nm. While, the second approach involved record-
ing the synchronous fluorescence spectra of the solutions 
by scanning at Δ λ = 100 nm and Δ λ = 80 nm in case of 
acidic and oxidative degradation, respectively. The second 
and first derivative synchronous fluorescence spectra were 
derived. The peak amplitudes of the second (2D) or the 
first (1D) derivative spectra were estimated at 346 nm and 
312.45  nm for acidic and oxidative degradation, respec-
tively. A blank experiment was performed simultaneously. 
The relative fluorescence intensity (RFI) or the peak ampli-
tude of the second (2D) or first (1D) derivative technique 
was then plotted against the final drug concentration in 
ng/mL to get the calibration graphs.
Analysis of ADP in semisolid pharmaceutical gel
An accurately weighed amount of the gel (0.1  g) was 
transferred into a clean dry 100  mL beaker and about 
80 mL of ethanol was added. The flasks were placed in a 
water bath at 50 °C for 15 min followed by cooling. The 
contents were quantitatively transferred into 100  mL 
volumetric flask, completed to the mark with the same 
solvent and filtered through cellulose acetate syringe fil-
ter. The subsequent dilutions were performed via diluting 
an appropriate volume of this solution with ethanol and 
the procedures described under “construction of calibra-
tion graphs” were then applied. The nominal content was 
determined either from the previously plotted calibration 
graph or using the corresponding regression equation.
Procedure for in vitro diffusion test
The release of ADP in 65 % hydroethanolic solution was 
carried out using a modified diffusion cell according to 
the method adopted by Deo et al. [12].
The donor half-cell consists simply of a glass tube 
with an open end (3  cm in diameter) on which a 
semipermeable cellulose membrane was stretched and 
fixed by rubber band to prevent leakage of water.
Five grams of Adapalene® gel were accurately weighed 
and thoroughly spread on the membrane to occupy 3 cm 
diameter circle. The donor cells were then immersed 
upside-down in 250 mL beaker containing 50 mL hydro-
ethanolic solution (65 %) (receptor compartment) which 
was preheated and maintained at 37 ±  1  °C using ther-
mostatically controlled water bath. The tubes height 
was adjusted, so that the membrane was just below the 
surface of the release medium. The whole assembly was 
shaken at 25 strokes per minute during the entire time of 
diffusion.
At the specified time interval, 2  mL was withdrawn 
from the receiver compartment and replaced by equal 
volume of fresh hydroethanolic solution and thus keep-
ing a constant volume. Dilution of 0.1 mL was performed 
with ethanol up to 10 mL in a volumetric flask. Appro-
priate volumes (0.1 mL) of this solution were then trans-
ferred to 10 mL volumetric flask, 2 mL of 0.2 M borate 
buffer (pH 7.0) was added and the volume was completed 
to the mark with ethanol. The % released amounts of 
ADP were determined by conventional fluorimetry at 
389 nm after excitation at 312 nm. Triplicate experiments 
were carried out for each sample.
Preparation of the degradation products
For degradation studies, working solution equivalent 
to 0.5  µg/mL was prepared by appropriate dilution of 
the stock solution with ethanol. Aliquots of 5 mL of this 
solution (equivalent to 2.5  µg) were then transferred 
into series of small conical flasks for alkaline, acidic and 
oxidative degradation. Then the following steps were 
performed:
For alkaline and acidic degradation Aliquots of 5 mL of 
2 M NaOH or different molarities of HCl (0.2–1 M) were 
added to the flasks. The solutions were heated in a boil-
ing water bath under reflux for different time intervals 
(10–60 min). At the specified time, the contents of each 
tube were cooled, neutralized to pH 7.0 and the solutions 
were then transferred into a series of 25 mL volumetric 
flasks. The volumes were completed with ethanol. Ali-
quots of these solutions (1.4 mL) were transferred into a 
series of 10 mL volumetric flasks, followed by addition of 
2.0 mL of 0.2 M borate buffer (pH 7.0) and completing the 
volumes to the mark using ethanol. The procedure under 
“construction of calibration graphs” for the first approach 
was then conducted.
For oxidative degradation Five milliliters of 5–30  % 
H2O2 were added to each flask. The solutions were then 
heated in a thermostatically controlled water bath at 80 °C 
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for different time intervals (10–60 min). At the specified 
time intervals, the contents of each flask were cooled and 
transferred to 25 mL volumetric flask. The volumes were 
completed to the mark with ethanol. The procedure men-
tioned under “construction of calibration graphs” for the 
first approach was then applied.
For day and  UV light degradation Suitable aliquots of 
the working solution (equivalent to 2.5  µg) were trans-
ferred into 25  mL volumetric flasks and completed to 
volume with ethanol. The flasks were left in day light 
or exposed to UV-light at 254 and 366 nm for 12 h in a 
wooden cabinet, where the distance between the source 
and the sample solution was kept at 15 cm. Aliquots of the 
solution (1.4 mL) were transferred into a series of 10 mL 
volumetric flasks and the procedure under ‘‘construction 
of calibration graphs’’ was then applied.
Results and discussion
From scanning the fluorescence spectra of ADP, it was 
found that ADP showed three different excitation peaks 
at wavelengths of 230, 265 and 312  nm and only one 
emission peak at 389 nm. In selection of excitation wave-
length, we emphasize on the linearity and reproducibility 
of the calibration graph even if the other excitation wave-
lengths showed higher sensitivity relative to the selected 
one. Consequently, ADP fluorescence was measured at 
389  nm after excitation at 312  nm (Fig.  2). Fortunately, 
the approach was extremely sensitive and allowed the 
determination of ADP in its pharmaceutical gel as alter-
native to the reported sophisticated HPLC methods. The 
high precision and accuracy of the approach made it ideal 
for in vitro diffusion test. Moreover, the inherent stabil-
ity of ADP was investigated using the forced degradation 
studies.
After preliminary studies, neither conventional nor syn-
chronous fluorimetry was able to resolve ADP from the 
degradation bands (Figs.  2, 3). Accordingly, we resorted 
to derivative synchronous fluorimetry which efficiently 
separated ADP from its acidic degradation product using 
SDSF and allowed its quantitation at 346  nm (Fig.  4a). 
Similarly, ADP was determined at 312.45 nm after appli-
cation of FDSF to resolve its band from the oxidative deg-
radation product (Fig.  4b). Thus, the stability-indicating 
power of this approach was ascertained.
Fig. 2 Fluorescence spectra of: A, A′ ADP (14.0 ng/mL) in borate 
buffer (pH 7.0)/ethanol system. B, B′ Blank (borate buffer (pH 7.0)/
ethanol system) where: (A, B) Excitation spectra. (A′, B′) Emission 
spectra






























































Fig. 3 Synchronous fluorescence spectra of: (a) (1) ADP (14.0 ng/mL) 
(2) acidic degradation product; at Δ λ = 80 nm (b) (1) ADP (14.0 ng/
mL) (2) oxidative degradation product; at Δλ = 100 nm
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Optimization of experimental conditions
Various experimental parameters affecting the fluores-
cence intensities of ADP were investigated to achieve the 
maximum sensitivity and the ultimate selectivity.
Effect of pH
To study the influence of pH on the fluorescence behav-
ior of ADP, different types of buffers covering the whole 
pH range were tested, such as 0.2 M acetate buffer (pH 
3.6–6) and 0.2 M borate buffer (pH 6.5–10), in addition 
to 0.1  M HCl and 0.1  M NaOH (Fig.  5). It was noticed 
that increasing the pH resulted in a proportional increase 
in the RFI of the drug up to 6.5, and then remained con-
stant up to pH 8.0, after which a precipitation occurred at 
pH 9 and 10. Therefore, borate buffer pH 7.0 was selected 
as the optimum pH giving the highest sensitivity. Also, 
trials were made by replacement of buffer by 0.1 M HCl 
or NaOH. Indeed, utilizing 0.1  M NaOH resulted in a 
high RFI but almost equal to the fluorescence intensity 
achieved upon utilizing 0.2  M borate buffer with pH 
7.0. And as a well-known fact that using buffer is more 
favorable to resist changes in pH values, so borate buffer 





























































Fig. 4 Second and first derivative synchronous fluorescence spectra 
of: (a) (1) (a–g) of ADP (2.0, 4.0, 6.0, 8.0, 10.0, 12.0, 14.0 ng/mL) at 
346 nm (2) acidic degradation product (b) (1) (a–g) of ADP (2.0, 4.0, 
6.0, 8.0, 10.0, 12.0, 14.0 ng/mL) at 312.45 nm (2) oxidative degradation 
product
























Fig. 5 Effect of pH on the native fluorescence intensity of ADP 
(14.0 ng/mL)
Table 1 Effect of  diluting solvents on  the relative fluores-
cence intensity of adapalene (14.0 ng/mL)



























Fig. 6 Effect of surfactant on the native fluorescence intensity of 
ADP (14.0 ng/mL)
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was selected. On the contrary, using 0.1 M HCl showed 
a marked quenching of the RFI of ADP which may be 
attributed to its degradation.
Effect of diluting solvent
Various solvents including water, methanol, acetoni-
trile, ethanol, n-propanol, dimethyl formamide (DMF) 
and acetone were tested to choose the most convenient 
diluting solvent. It is noticeable from Table  1 that etha-
nol gave the highest fluorescence intensity so; it was the 
solvent of choice. Also, n-propanol could be used. High 
blank reading was observed in case of using methanol at 
this wavelength. Water and acetonitrile showed a marked 
decrease in the fluorescence intensity so they were not 
selected. The initiated intersystem crossing process 
caused by DMF made it unsuitable for ADP determina-
tion as it resulted in a marked decrease in the fluores-
cence intensity of ADP in addition to high blank reading 
[13]. Complete quenching of the fluorescence intensity 
was attained upon using acetone.
Effect of surfactant
Study of the impact of the surfactant was accomplished 
using 0.5 % aqueous solutions of anionic surfactant (SDS), 
cationic surfactant (CTAB), non-ionic surfactant (tween-
80) and different macromolecules such as methyl cel-
lulose, and β-CD. As shown in Fig.  6, these surfactants 
didn’t significantly affect the fluorescence intensity of 
Table 2 Analytical performance data for the proposed approaches
Parameters The first approach  
at 389 nm
The second approach
SDSF at 346 nm FDSF at 312.45 nm
Linearity range (ng/mL) 2.0–14.0 2.0–14.0 2.0–14.0
Intercept (a) −4.714 −1.212 5.171
Slope (b) 35.357 3.975 3.729
Correlation coefficient (r) 0.9999 0.9998 0.9998
SD of residuals (Sy/x) 1.59 0.34 0.31
SD of intercept (Sa) 1.34 0.29 0.26
SD of slope (Sb) 0.15 0.03 0.03
Percentage relative standard deviation, % RSD 0.42 0.88 0.76
Percentage relative error, % error 0.16 0.33 0.29
Limit of detection, LOD (ng/mL) 0.13 0.24 0.23
Limit of quantitation, LOQ (ng/mL) 0.38 0.73 0.69
Table 3 Application of the proposed approaches for the determination of adapalene in pure form
N.B. Each result is the average of three separate determinations
* The values between parentheses are the tabulated t and F values at P = 0.05 [15]
Parameter Amount  
taken (ng/mL)
First approach at 389 nm Second approach Comparison method [3]
Amount  
found (ng/mL)











ADP 2.0 2.00 100.00 1.991 1.992 99.54 99.62 20.0 99.22
4.0 4.008 100.20 4.001 3.977 100.02 99.43 30.0 99.88
6.0 5.988 99.80 5.976 5.962 99.59 99.36 40.0 101.15
8.0 8.053 100.66 8.134 8.000 101.68 100.00
10.0 9.948 99.48 9.915 10.146 99.15 101.46
12.0 11.956 99.63 11.918 12.023 99.31 100.19
14.0 14.049 100.35 14.066 13.900 100.47 99.29
Mean 100.02 99.97 99.91 100.08
SD 0.42 0.88 0.76 0.98
t 1.06 (2.31)* 0.73 (2.31) 0.93 (2.31)
F 2.88 (5.14)* 1.53 (19.33) 1.16 (19.33)
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ADP. Consequently, they were not incorporated in the 
procedure.
Selection of optimum Δ λ in the second approach
Selection of optimum Δ λ is a very essential criterion 
which should be considered during scanning of the 
synchronous fluorimetry as it may significantly affect 
sensitivity, resolution and symmetry of the bands. Con-
sequently, a wide range of Δ λ (20–140 nm) was investi-
gated. Good band shapes and adequate sensitivity were 
obtained upon using Δ λ of 80 and 100  nm in case of 
acidic and oxidative degradation, respectively. Lower and 
higher values of Δ λ than the optimum ones showed low 
fluorescence intensity for ADP and its degradation prod-
ucts. However, very low and very high Δ λ values caused 
irregularities in the spectral shape.
Validation of the approaches
Linearity
It was investigated via replicate analysis of seven standard 
concentrations of ADP; 2.0, 4.0, 6.0, 8.0, 10.0, 12.0, 14.0 ng/
mL. Calibration graphs of ADP were constructed by plot-
ting either the RFI or the peak amplitude of (2D) or (1D) 
against the drug concentration in ng/mL. The results of 
the regression equations and correlation coefficients were 
abridged in Table 2. In the approaches, good linearity for 
ADP was achieved in the range of 2.0–14.0 ng/mL as indi-
cated by higher value of correlation coefficients (>0.999).
Limit of quantitation (LOQ) and limit of detection (LOD)
These analytical parameters were computed by the equa-
tions specified by ICH Q2R1 recommendations [14] and 
were presented in Table 2:
where Sa = standard deviation of the intercept of the cali-
bration curve and b = slope of the calibration curve.
Accuracy and precision
The results of the present approaches were statistically 
compared with those of the comparison method [3] to 
ascertain these analytical features. No significant differ-
ence was observed using Student’s t test and variance 
ratio F test [15]. The excellent recovery values demon-
strated that the approaches were sufficiently accurate 
over the specified range (Table 3).
The comparison HPLC method [3] was carried out on 
C8 column using a blend of methanol: ammonium ace-
tate buffer pH 4.0 (80:20, v/v) as a mobile phase and UV 
detection at 270 nm.
The repeatability and intermediate precision of the applied 
approaches were determined using three concentrations 
LOQ = 10 Sa/b and LOD = 3.3 Sa/b
and three replicates of each concentration within the same 
day or 3 different days. Small values of the relative stand-
ard deviations gave a good indication for the high precision 
which characterizes these approaches (Table 4).
Selectivity
The proposed approaches were found to be selective for 
ADP in its gel, where, satisfactory results were obtained 
and no interference was observed (Table  5). Moreover, 
the derivative synchronous fluorimetry was found to be 




The present fluorimetric approaches were applied to the 
analysis of ADP. Four samples were determined and three 
replicate of each one. Satisfactory results were obtained 
Table 4 Precision data for the determination of adapalene 
applying the proposed approaches
Amount taken (ng/mL) % found % RSD % error
The first approach at 389 nm
 Intraday
  6.0 100.11 ± 0.85 0.85 0.49
  8.0 100.55 ± 0.37 0.37 0.21
  10.0 99.88 ± 0.17 0.17 0.10
 Interday
  6.0 101.05 ± 1.15 1.14 0.66
  8.0 99.93 ± 1.22 1.22 0.70
  10.0 99.85 ± 0.55 0.55 0.32
The second approach
 SDSF at 346 nm
  Intraday
   6.0 99.67 ± 0.77 0.77 0.44
   8.0 99.50 ± 0.25 0.25 0.14
   10.0 100.02 ± 0.31 0.31 0.18
  Interday
   6.0 100.04 ± 0.81 0.81 0.47
   8.0 99.02 ± 0.97 0.98 0.57
   10.0 98.28 ± 1.13 1.15 0.66
 FDSF at 312.45 nm
  Intraday
   6.0 99.20 ± 0.91 0.92 0.53
   8.0 100.08 ± 0.77 0.77 0.44
   10.0 99.31 ± 0.42 0.42 0.24
  Interday
   6.0 101.19 ± 1.37 1.35 0.78
   8.0 99.74 ± 0.90 0.90 0.52
   10.0 98.11 ± 1.09 1.11 0.65
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for ADP in a good agreement with the label claims and 
no interference was observed (Table 5).
Statistical analysis of the results obtained by the pro-
posed approaches and the comparison [3] method 
using Student’s t test and variance ratio F test at 95  % 
confidence level [15] revealed no significant difference 
between the performance of the approaches regarding 
the accuracy and precision, respectively.
In‑vitro diffusion test
The easy and excellent applicability of the first approach 
for the determination of ADP in its pharmaceutical gel 
encouraged us to conduct the in vitro diffusion test and 
to study the percentage of its release. In-vitro release pro-
file of ADP from its gel in hydroethanolic solution (65 %) 
is shown in Fig. 7. It was found that increasing the time 
resulted in a subsequent increase in the % release up to 
3.5 h where it reach the maximum (30 %) after which no 
more release was attained.
Stability studies
In forced degradation studies, the parent drug or the drug 
product is subjecting to different stress conditions. These 
studies play an essential role in establishing the intrinsic 
stability of the drug and hence help in selecting the suit-
able pharmaceutical dosage forms, solving the problems 
which may be appeared during the stages of storage and 
packaging. Main degradation pathways involve acidic/
basic hydrolysis, oxidative, and photolytic-degradation.
According to ICH [11] guidelines, only small amount of 
data concerned with methodology and basics for estab-
lishing a new forced degradation study was available. 
Also, the required amount of the applied stress is not 
sufficiently discussed. Stress conditions should be real-
istic and not excessive. So, our target was concentrated 
on giving an appropriate and relevant degradation about 
(10–30  %) and separating the produced degradation 
products from the parent drug as possible.
Different forced degradation studies were tried to 
study the inherent stability of ADP. ADP was not sus-
ceptible to alkaline degradation as evidenced by boiling 
with 2  M NaOH for 2  h. On the other hand, ADP was 
strongly affected by acidic condition as preliminary stud-
ies showed that almost all the drug was degraded upon 
Table 5 Application of the proposed approaches for the determination of adapalene in its pharmaceutical Adapalene® 
gel
N.B. Each result is the average of three separate determinations
The tabulated t and F values are 2.57 and 9.55, respectively at P = 0.05 [15]























6.0 5.957 99.28 5.932 6.072 98.87 101.20 20.0 100.07
(0.1 % ADP) 8.0 8.082 101.03 7.922 8.026 99.03 100.33 30.0 98.80
Batch # 011371 10.0 10.007 100.07 10.022 9.905 100.22 99.05 40.0 101.03
12.0 11.900 99.17 11.972 11.986 99.77 99.88
Mean 99.89 99.47 100.12 99.97
S.D. 0.86 0.63 0.90 1.12
t 0.11 0.75 0.19
F 1.69 3.11 1.56












Fig. 7 The % release of ADP from adapalene® gel
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boiling with 1 M HCL for only 10 min. So, we directed 
to use 0.3  M HCl instead where 28  % of the drug was 
degraded after boiling for 10 min.
Similarly, ADP was susceptible to oxidative conditions 
and the percentage of degradation was dependent on the 
strength of the used hydrogen peroxide. After heating 
ADP with 30 % H2O2 solution at 80 °C for 10 min., about 
30 % of ADP was degraded.
The impact of day light on the stability of ADP was 
checked after leaving its ethanolic solution on the bench 
in day light for 12  h and no considerable degradation 
was observed. Also, the solution of ADP in ethanol was 
exposed to UV light at two different wave lengths; 254 
and 366 nm for 12 h to manifest the effect of UV light 
on its stability. About 25 % of ADP was degraded at the 
mentioned wavelengths. Unfortunately, the photolytic 
degradation product was not separated from the intact 
drug in contrast to acidic and oxidative degradation 
products.
Pathway of ADP degradation
The molecular rigidity is a key element in enhancing the 
fluorescence behavior of many compounds as it pre-
vents the internal conversion. Loss of rigidity of ADP 
is proposed under acidic stress condition via breakage 
of adamantine group and consequently fluorescence 
diminishes. As ADP being a naphthalene derivative, its 
photolytic irradiation may result in the degradation of 
naphthalene moiety into the corresponding 2-formyl 
cinnamaldehyde one [16, 17]. While, upon heating ADP 
with 30 % H2O2 it undergoes oxidative degradation with 
the formation of 1,4-naphthoquinone derivative. The 
pathway of the degradation process was proposed and 
postulated in Scheme 1.
Conclusions
The proposed approaches described highly sensitive and 
simple fluorimetric methods for the quantitative assay of 
a small concentration of ADP in its pharmaceutical gel 
alternative to the reported sophisticated HPLC methods 
[3–8] or the non-sensitive derivative spectrophotomet-
ric ones [9, 10]. The conventional spectrofluorimetry was 
ideally suited for in  vitro diffusion test. Stability studies 
were also conducted using different forced degradation 
condition according to ICH recommendation. Fortu-
nately, second and first derivative synchronous fluorim-
etry were capable to resolve the band of ADP from its 
acidic and oxidative degradation products at 346 and 
312.45  nm after recording the synchronous fluorimetry 
using Δ λ of 80 and 100 nm, respectively. Consequently, 



























Scheme 1 The assumed pathways of acidic, oxidative and UV light degradation of ADP
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